Kiromic Biopharma, Inc. Shareholder News: Robbins LLP is Investigating Kiromic Biopharma, Inc. (KRBP) on Behalf of ShareholdersBusiness Wire • 08/22/22
CLASS ACTION NOTICE: Kessler Topaz Meltzer & Check, LLP Reminds Kiromic BioPharma, Inc. Shareholders of Securities Fraud Class Action LawsuitNewsfile Corp • 08/22/22
KRBP CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Kiromic BioPharma, Inc. Shareholders of Securities Fraud Class Action LawsuitPRNewsWire • 08/20/22
ROSEN, A LEADING LAW FIRM, Encourages Kiromic BioPharma, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - KRBPNewsfile Corp • 08/19/22
Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Lawsuit Filed against Kiromic BioPharma, Inc. (KRBP) and Encourages Investors with Significant Losses to Contact the FirmBusiness Wire • 08/19/22
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Investors in Kiromic BioPharma, Inc. (KRBP) with Significant Losses to Contact Firm's Attorneys, Securities Class Action PendingNewsfile Corp • 08/19/22
Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Kiromic BioPharma, Inc. (KRBP) Investors of Class Action and to Actively ParticipateBusiness Wire • 08/18/22
KRBP ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 4, 2022 in the Class Action Filed on Behalf of Kiromic BioPharma, Inc. Limited ShareholdersNewsfile Corp • 08/18/22
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Investors in Kiromic BioPharma, Inc. (KRBP) with Significant Losses to Contact Firm's Attorneys, Deadline Established in Securities Class ActionNewsfile Corp • 08/17/22
KRBP INVESTOR NEWS: ROSEN, A LEADING NATIONAL FIRM, Encourages Kiromic BioPharma, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - KRBPPRNewsWire • 08/15/22
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Investors in Kiromic BioPharma, Inc. (KRBP) with Significant Losses to Contact Firm's Attorneys, Securities Class Action FiledPRNewsWire • 08/15/22
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Kiromic BioPharma, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - KRBPNewsfile Corp • 08/13/22
Kiromic Biopharma, Inc. Shareholder Update: Robbins LLP Reminds Investors of Class Action Against Kiromic Biopharma, Inc. (KRBP)Business Wire • 08/12/22
EQUITY ALERT: Rosen Law Firm Encourages Kiromic BioPharma, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – KRBPBusiness Wire • 08/10/22
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Kiromic Biopharma, Inc. (KRBP)Business Wire • 08/10/22
KIROMIC ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Kiromic BioPharma, Inc. and Encourages Investors to Contact the FirmBusiness Wire • 08/10/22
Kiromic BioPharma Appoints Leonardo Mirandola, Ph.D. as Chief Scientific OfficerBusiness Wire • 07/12/22
Kiromic BioPharma Achieves Milestone with Timely Completion of Expanded cGMP Manufacturing Facility to Support Cell Therapy Oncology PipelineBusiness Wire • 07/07/22
Kiromic BioPharma Pipeline to Prioritize a New Gamma Delta T-cell Product CandidateBusiness Wire • 06/21/22